Innate IFN‐lambda responses to dsRNA in the human infant airway epithelium and clinical regulatory factors during viral respiratory infections in early life

• Published in: Clinical and experimental allergy Vol. 50; no. 9; pp. 1044 - 1054
• Main Authors: Salka, Kyle, Arroyo, Maria, Chorvinsky, Elizabeth, Abutaleb, Karima, Perez, Geovanny F., Wolf, Seth, Xuchen, Xilei, Weinstock, Jered, Gutierrez, Maria J., Pérez‐Losada, Marcos, Pillai, Dinesh K., Nino, Gustavo
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.09.2020
• Subjects: airway epithelium; Case-Control Studies; Cells, Cultured; Child, Preschool; Children; Double-stranded RNA; Epithelial cells; Epithelial Cells - immunology; Epithelial Cells - metabolism; Epithelial Cells - virology; Epithelium; Female; Host Microbial Interactions; Humans; IFN‐lambda; Immunity, Innate; Infant; Infants; Infections; Inflammation; Interferon; Interferons - immunology; Interferons - metabolism; Interleukin 1; Male; MAP kinase; NF-kappa B - metabolism; p38 Mitogen-Activated Protein Kinases - metabolism; pediatrics; Poly I-C - immunology; Polyinosinic:polycytidylic acid; Respiratory diseases; Respiratory System - immunology; Respiratory System - metabolism; Respiratory System - virology; Respiratory tract; Respiratory tract infection; Respiratory Tract Infections - immunology; Respiratory Tract Infections - metabolism; Respiratory Tract Infections - virology; RNA, Double-Stranded - immunology; Signal Transduction; viral bronchiolitis; Viral infections; Viral Load; virus; Virus Diseases - immunology; Virus Diseases - metabolism; Virus Diseases - virology; Wheezing; IFN-lambda; epithelium; viral bronchiolitis; virus; airway epithelium; pediatrics
• ISSN: 0954-7894; 1365-2222; 1365-2222
• DOI: 10.1111/cea.13701

Introduction IFN lambda (type III‐IFN‐λ1) is a molecule primarily produced by epithelial cells that provides an important first‐line defence against viral respiratory infections and has been linked to the pathogenesis of viral‐induced wheezing in early life. The goal of this study was to better understand the regulation of innate IFN‐lambda responses in vitro in primary human infant airway epithelial cells (AECs) and in vivo using nasal aspirates during viral respiratory infections. Methods IFN‐lambda protein levels were quantified: (a) in human infant AECs exposed to (poly(I:C) dsRNA) under different experimental conditions (n = 8 donors); and (b) in nasal aspirates of young children (≤3 years) hospitalized with viral respiratory infection (n = 138) and in uninfected controls (n = 74). In vivo IFN‐lambda airway levels during viral infections were correlated with individual characteristics and respiratory disease parameters. Results Our in vitro experiments showed that the poly(I:C)‐induced innate production of IFN lambda in human infant AECs is regulated by (a) p38‐MAPK/NF‐kB dependent mechanism; and (b) exposure to pro‐inflammatory signals such as IL1β. Our in vivo studies demonstrated that (a) infants (<18 months) had higher virus‐induced IFN‐lambda airway secretion; (b) subjects with RSV infection showed the highest IFN‐lambda airway levels; and (c) individuals with the highest virus‐induced IFN‐lambda levels (>90th percentile) had higher viral loads and were more likely to have respiratory sick visits within 12 months of discharge (OR = 5.8). Conclusion IFN‐lambda responses to dsRNA in the human infant airway epithelium are regulated by p38‐MAPK and NF‐kB signalling. High in vivo IFN‐lambda production is influenced by virus type and associated with recurrent respiratory sick visits in young children.